Corrections to “Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines”
Matti Aapro(Clinique de Genolier), Jørn Herrstedt(Zealand University Hospital), R. Stauder, T. Littlewood, P. Pronzato(Accademia Nazionale dei Lincei), Yves Béguin(University of Liège), Pere Gascón(Merck KGaA, Darmstadt (Germany)), D. Schrijvers, Anders Österborg(Karolinska University Hospital), Axel Hofmann(The University of Western Australia), John A. Glaspy(University of California, Los Angeles), Kim Jordan, H. Ludwig(Universitätsmedizin Göttingen), Valeria Santini(Azienda Ospedaliero-Universitaria Careggi), Mario Dicato(Centre Hospitalier de Luxembourg), C. Bokemeyer(Universität Hamburg), Heike E. Daldrup‐Link(Lucile Packard Children's Hospital)
Cited by 45
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
|Annals of Oncology|2018|1.2k